A Study of Galcanezumab in Participants With Chronic Cluster Headache
I5Q-MC-CGAM - ClinicalTrials.gov - NCT02438826
The main purpose of this study is to evaluate the efficacy of the study drug known as LY2951742 in participants with chronic cluster headache.
Trial Summary
Age Range
18 - 65 yearsConditions the trial is for
Chronic Cluster HeadacheWhat the trial is testing?
GalcanezumabCould I receive a Placebo?
YesEnrollment Goal
240Trial Dates
Jun 18, 2015 - Aug 14, 2019How long will I be in the trial?
Your participation will include scheduled office visits throughout the study period.Trial Phase
IIILilly Trial Alerts
Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.
You will complete the questionnaire on another website.YesNo